Treatment with vutrisiran in people with transthyretin amyloidosis with cardiomyopathy: a plain language summary
Ronald Witteles, Marianna Fontana, Fran M Kochman, Mathew S. Maurer et al.
Citations
2 citations
Journal
Future Cardiology
Topics
Amyloidosis: Diagnosis, Treatment, Outcomes
Field-Weighted Citation Impact (FWCI)
1.61
article
Treatment with vutrisiran in people with transthyretin amyloidosis with cardiomyopathy: a plain language summary
Ronald Witteles, Marianna Fontana, Fran M Kochman, Mathew S. Maurer, Julian D. Gillmore, Ann Payne, Satish A. Eraly, Michael Dworkin, Ben Laryea
article en
2 citations
Abstract
No abstract available for this paper.
Publication Tag
Future CardiologyVol. 21(8)
Institutions
Alnylam Pharmaceuticals (United States) (US), Columbia University Irving Medical Center (US), The Royal Free Hospital (GB), Amyloidosis Foundation (US), Immunomedics (United States) (US), University College London (GB), Stanford University (US)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Treatment with vutrisiran in people with transthyretin amyloidosis with cardiomyopathy: a plain language summary — Ronald Witteles, Marianna Fontana, et al. · Future Cardiology (2025) | TGRS Research Map | TGRS